SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

UBS Maintains Sell on Mednax, Lowers Price Target to $11

UBS maintains Mednax (NYSE:MD) with a Sell and lowers the price target from $18 to $11.

Benzinga · 05/08/2020 16:49

UBS maintains Mednax (NYSE:MD) with a Sell and lowers the price target from $18 to $11.